Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;36(6):4133-41.
doi: 10.1007/s13277-015-3047-5. Epub 2015 Jan 15.

SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism

Yan Sun  1 , Weiwei He, Man Luo, Yuhong Zhou, Guilin Chang, Weiying Ren, Kefen Wu, Xi Li, Jiping Shen, Xiaoping Zhao, Yu Hu
Affiliations

SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism

Yan Sun et al. Tumour Biol. 2015 Jun.

Abstract

Sterol regulatory element-binding protein 1 (SREBP1) is a known transcription factor of lipogenic genes, which plays important roles in regulating de novo lipogenesis. Accumulating evidences indicate SREBP1 is involved in tumorigenesis, yet its role in pancreatic cancer remains unclear. Here, we explored the expression characteristic and function of SREBP1 in pancreatic cancer. Analysis of 60 patients with pancreatic ducat cancer showed that SREBP1 level was significantly higher in pancreatic cancer than that in adjacent normal tissues. High expression of SREBP1 predicted poor prognosis in patients with pancreatic cancer. Multivariate analysis revealed that SREBP1 was an independent factor affecting overall survival. SREBP1 silencing resulted in proliferation inhibition and induction of apoptosis in pancreatic cancer cells. Mechanistically, lipogenic genes (acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), and stearoyl-CoA desaturase-1 (SCD1)) and de novo lipogenesis were promoted by SREBP1. Inhibition of lipogenic genes through specific inhibitors ablated SREBP1-mediated growth regulation. Furthermore, depletion of SREBP1 could suppress lipid metabolism and tumor growth in vivo. Our results indicate that SREBP1 had important role in tumor progression and appears to be a novel prognostic marker for pancreatic cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mol Cancer. 2011 Jun 07;10:70 - PubMed
    1. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2380-5 - PubMed
    1. Metabolism. 2014 Jul;63(7):895-902 - PubMed
    1. World J Gastroenterol. 2014 Mar 7;20(9):2279-303 - PubMed
    1. Cell. 2011 Nov 11;147(4):840-52 - PubMed

Publication types

Substances

LinkOut - more resources